13 okt ,2017

BSc/MSc organic synthesis

We are looking for A synthetic organic chemist (BSc or MSc) to strengthen our process R&D team for small molecules. In this position you will: independently and in teams work on process R&D for API’s; interact with colleague in analytics, manufacture, and QA for the execution of projects; writing of technical reports in English; develop […]

READ MORE
13 okt ,2017

BSc/MSc nano medicines R&D

We are looking for A synthetic organic chemist (BSc or MSc) to strengthen our process R&D team for nanomedicines. In this position you will: independently and in teams work on process R&D for nanomedicines; interact with colleague in analytics, manufacture, and QA for the execution of projects; writing of technical reports in English; develop scientific, […]

READ MORE

Older news

07 jun ,2017

Associate Scientist Analytical Sciences

VACATURE Associate Scientist Analytical Sciences Wij zijn ChemConnection Opgericht in 2012 zijn we inmiddels uitgegroeid tot ~50 medewerkers. Onze passie is (analytische) chemie en nanomedicijnen. Ons doel is om uitdagende farmaceutische grondstoffen en producten te ontwikkelen, samen met onze klanten. Wij bieden technologie en expertise om deze Active Pharmaceutical Ingredients en/of Nanomedicines projecten naar de […]

Further reading >
24 apr ,2017

PhD organic synthesis

About ChemConnection ChemConnection is a young, dynamic, and very innovative pharmaceutical company. As a CDMO (custom development and manufacturing organization) we support other pharmaceutical companies with the development of their new products. ChemConnection is specialized in process and analytical development and cGMP manufacture of Active Pharmaceutical Ingredients (API) and nanomedicines. ChemConnection has a globally leading […]

Further reading >
06 sep ,2016

Austin Chemical Company, Syncom, and ChemConnection announce partnership and establish joint venture SynConnection LLC

BUFFALO GROVE (IL, USA), GRONINGEN (The Netherlands), OSS (The Netherlands), 6 September 2016 – Austin Chemical Company Inc, a pharmaceutical procurement and logistics service provider announced today the joint venture with Syncom BV, a pharmaceutical contract synthesis company, and ChemConnection BV, a GMP licensed contact manufacturing company. The development of novel active pharmaceutical ingredients (NCEs, […]

Further reading >
16 jun ,2016

CHEMCONNECTION AND CRISTAL THERAPEUTICS ANNOUNCE SUCCESSFUL GMP PRODUCTION OF CRIPEC® DOCETAXEL FOR PHASE 1/2A CLINICAL TRIALS

Oss and Maastricht, The Netherlands, June 1, 2016 – ChemConnection, a privately-held company manufacturing nanomedicines, bioconjugates, peptides, and small molecules, announces the successful GMP production of CriPec® docetaxel for its customer Cristal Therapeutics, a privately-held life sciences company developing nanomedicines against cancer and other diseases. “ChemConnection has made a tremendous leap forward in becoming the […]

Further reading >
26 jan ,2016

Renewal GMP license

January 21, ChemConnection was audited by the Dutch health authorities (IGZ). The audit was very successful and has resulted in the renewal of the GMP manufacturing license for API and bulk drug product. With the licenses in place, ChemConnection continues its leading role in nanomedicine development and manufacturing

Further reading >
12 nov ,2015

ChemConnection is hiring

ChemConnection has a job vacancy for an early stage researcher (PhD candidate) for the NANOMED European Training Network. The application deadline is November 23, 2015. Please download the job description for a detailed overview of this vacancy.

Further reading >
07 okt ,2015

ChemConnection present at BioEurope 2015

ChemConnection will be present at the autumn edition of BioEurope in Munich, November 2015. Please contact us via the partnering network, or send us an email message to organize an appointment. ChemConnection will be represented by our scientific advisor nanomedicines Dr. Marcel van der Sluis.

Further reading >
26 mei ,2015

Horizon2020 Program

Horizon2020 program for Bio-Organic Chemistry group of the Radboud University Nijmegen, The Netherlands The bio-organic chemistry group of the Institute for Molecules and Materials (IMM) of the Radboud University Nijmegen, The Netherlands, has been awarded a 3.9 M€ ITN consortium on nanomedicine from the Horizon2020 program. Under supervision of the IMM a special training program […]

Further reading >
Menu
class="last-menu-item menu-itemve-menu" class="">
  • Drug Substances
  • Nanomedicines
  • Analytical Sciences
  • About us
  • Contact